Single answer
Is Amneal Pharmaceuticals Inc (AMRX) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
$1 invested is now $1.25 or 25.44%
(In 16 weeks 22 hours 53 minutes and 27 seconds .)
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Amneal Pharmaceuticals Inc is $15.00, which is $0.350 (2.39%) above the current price today's price.
Low target: $15.00 | High target: $15.00
Latest analyst updates
Recent rating and price target changes for this stock.
Company snapshot
A quick overview of the business and its public profile.
Amneal Pharmaceuticals Inc together with its subsidiaries develops licenses manufactures markets and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas The company operates through three segments Generics Specialty and AvKARE The Generics segment develops manufactures and commercializes complex oral solids injectables ophthalmics liquids topicals softgels inhalation products and transdermals across a range of therapeutic categories The Specialty segment is involved in the development promotion distribution and sale of branded pharmaceutical products with focus on central nervous system disorders endocrinology parasitic infections and other therapeutic areas It also offers Emverm a chewable tablet for the treatment of pinworm whipworm common roundworm common hookworm and American hookworm in single or mixed infections Rytary to treat Parkinsons disease and Unithroid for the treatment of hypothyroidism The AvKARE segment provides pharmaceuticals medical and surgical products and services primarily to governmental agencies the Department of Defense and the Department of Veterans Affairs It is also involved in the wholesale distribution of bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names as well as medical and surgical products and packaging and wholesale distribution of pharmaceuticals and vitamins to its retail and institutional customers The company sells its products through wholesalers distributors hospitals chain pharmacies and individual pharmacies It operates in the United States India Ireland and internationally The company was formerly known as Atlas Holdings Inc and changed its name to Amneal Pharmaceuticals Inc in 2018 Amneal Pharmaceuticals Inc was founded in 2002 and is headquartered in Bridgewater New Jersey
Website: https://www.amneal.com
Rates and inflation backdrop
US inflation for January 2026 was 0.17%. Over the last 12 months, inflation is 2.83%. The 10-year yield is 4.04 and is down -0.110 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.75. Cash flow to debt ratio: 0.12. Net profit margin: 0.20%. Inflation risk score: medium (0.65/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Amneal Pharmaceuticals Inc is $27.4M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
On Amneal Pharmaceuticals Inc, 2016-02-26 had a stock price of $33.27. If you invested back then, your return now would be a loss of $18.69 per share or 56.18%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.